Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Genome-wide DNA methylomic differences between dorsolateral prefrontal and temporal pole cortices of bipolar disorder.

Ho AM, Winham SJ, Armasu SM, Blacker CJ, Millischer V, Lavebratt C, Overholser JC, Jurjus GJ, Dieter L, Mahajan G, Rajkowska G, Vallender EJ, Stockmeier CA, Robertson KD, Frye MA, Choi DS, Veldic M.

J Psychiatr Res. 2019 Jun 26;117:45-54. doi: 10.1016/j.jpsychires.2019.05.030. [Epub ahead of print]

PMID:
31279243
2.

Type 1 equilibrative nucleoside transporter (ENT1) regulates sex-specific ethanol drinking during disruption of circadian rhythms.

Jia YF, Vadnie CA, Ho AM, Peyton L, Veldic M, Wininger K, Matveyenko A, Choi DS.

Addict Biol. 2019 Jul 2:e12801. doi: 10.1111/adb.12801. [Epub ahead of print]

PMID:
31267611
3.

Genetic variant in SLC1A2 is associated with elevated anterior cingulate cortex glutamate and lifetime history of rapid cycling.

Veldic M, Millischer V, Port JD, Ho AM, Jia YF, Geske JR, Biernacka JM, Backlund L, McElroy SL, Bond DJ, Villaescusa JC, Skime M, Choi DS, Lavebratt C, Schalling M, Frye MA.

Transl Psychiatry. 2019 May 23;9(1):149. doi: 10.1038/s41398-019-0483-9.

4.

Chronic caffeine exposure in adolescence promotes diurnal, biphasic mood-cycling and enhanced motivation for reward in adult mice.

Hinton DJ, Andres-Beck LG, Nett KE, Oliveros A, Choi S, Veldic M, Choi DS.

Behav Brain Res. 2019 Sep 16;370:111943. doi: 10.1016/j.bbr.2019.111943. Epub 2019 May 13.

PMID:
31095992
5.

Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications.

Veldic M, Ahmed AT, Blacker CJ, Geske JR, Biernacka JM, Borreggine KL, Moore KM, Prieto ML, Vande Voort JL, Croarkin PE, Hoberg AA, Kung S, Alarcon RD, Keeth N, Singh B, Bobo WV, Frye MA.

Front Pharmacol. 2019 Feb 19;10:83. doi: 10.3389/fphar.2019.00083. eCollection 2019.

6.

A Review of Epigenetics of PTSD in Comorbid Psychiatric Conditions.

Blacker CJ, Frye MA, Morava E, Kozicz T, Veldic M.

Genes (Basel). 2019 Feb 13;10(2). pii: E140. doi: 10.3390/genes10020140. Review.

7.

Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure.

Ahmed AT, Biernacka JM, Jenkins G, Rush AJ, Shinozaki G, Veldic M, Kung S, Bobo WV, Hall-Flavin DK, Weinshilboum RM, Wang L, Frye MA.

J Affect Disord. 2019 Mar 1;246:62-68. doi: 10.1016/j.jad.2018.12.021. Epub 2018 Dec 17.

8.

Association of schizophrenia polygenic risk score with manic and depressive psychosis in bipolar disorder.

Markota M, Coombes BJ, Larrabee BR, McElroy SL, Bond DJ, Veldic M, Colby CL, Chauhan M, Cuellar-Barboza AB, Fuentes M, Kung S, Prieto ML, Rummans TA, Bobo WV, Frye MA, Biernacka JM.

Transl Psychiatry. 2018 Sep 10;8(1):188. doi: 10.1038/s41398-018-0242-3.

9.

Exploring hepsin functional genetic variation association with disease specific protein expression in bipolar disorder: Applications of a proteomic informed genomic approach.

Nassan M, Jia YF, Jenkins G, Colby C, Feeder S, Choi DS, Veldic M, McElroy SL, Bond DJ, Weinshilboum R, Biernacka JM, Frye MA.

J Psychiatr Res. 2017 Dec;95:208-212. doi: 10.1016/j.jpsychires.2017.07.005. Epub 2017 Jul 4.

PMID:
28886448
10.

Metabotropic glutamate receptors as emerging research targets in bipolar disorder.

Blacker CJ, Lewis CP, Frye MA, Veldic M.

Psychiatry Res. 2017 Nov;257:327-337. doi: 10.1016/j.psychres.2017.07.059. Epub 2017 Jul 31. Review.

PMID:
28800512
11.

Differential SLC1A2 Promoter Methylation in Bipolar Disorder With or Without Addiction.

Jia YF, Choi Y, Ayers-Ringler JR, Biernacka JM, Geske JR, Lindberg DR, McElroy SL, Frye MA, Choi DS, Veldic M.

Front Cell Neurosci. 2017 Jul 21;11:217. doi: 10.3389/fncel.2017.00217. eCollection 2017.

12.

Genetic Risk Score Analysis in Early-Onset Bipolar Disorder.

Croarkin PE, Luby JL, Cercy K, Geske JR, Veldic M, Simonson M, Joshi PT, Wagner KD, Walkup JT, Nassan MM, Cuellar-Barboza AB, Casuto L, McElroy SL, Jensen PS, Frye MA, Biernacka JM.

J Clin Psychiatry. 2017 Nov/Dec;78(9):1337-1343. doi: 10.4088/JCP.15m10314.

13.

A genome wide association study suggests the association of muskelin with early onset bipolar disorder: Implications for a GABAergic epileptogenic neurogenesis model.

Nassan M, Li Q, Croarkin PE, Chen W, Colby CL, Veldic M, McElroy SL, Jenkins GD, Ryu E, Cunningham JM, Leboyer M, Frye MA, Biernacka JM.

J Affect Disord. 2017 Jan 15;208:120-129. doi: 10.1016/j.jad.2016.09.049. Epub 2016 Sep 30.

PMID:
27769005
14.

Clinical features of bipolar spectrum with binge eating behaviour.

McElroy SL, Crow S, Blom TJ, Cuellar-Barboza AB, Prieto ML, Veldic M, Winham SJ, Bobo WV, Geske J, Seymour LR, Mori N, Bond DJ, Biernacka JM, Frye MA.

J Affect Disord. 2016 Sep 1;201:95-8. doi: 10.1016/j.jad.2016.05.003. Epub 2016 May 6.

PMID:
27195513
15.

Prevalence and correlates of DSM-5 eating disorders in patients with bipolar disorder.

McElroy SL, Crow S, Blom TJ, Biernacka JM, Winham SJ, Geske J, Cuellar-Barboza AB, Bobo WV, Prieto ML, Veldic M, Mori N, Seymour LR, Bond DJ, Frye MA.

J Affect Disord. 2016 Feb;191:216-21. doi: 10.1016/j.jad.2015.11.010. Epub 2015 Nov 19.

PMID:
26682490
16.

Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorder.

Nassan M, Croarkin PE, Luby JL, Veldic M, Joshi PT, McElroy SL, Post RM, Walkup JT, Cercy K, Geske JR, Wagner KD, Cuellar-Barboza AB, Casuto L, Lavebratt C, Schalling M, Jensen PS, Biernacka JM, Frye MA.

Bipolar Disord. 2015 Sep;17(6):645-52. doi: 10.1111/bdi.12323.

17.

Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses.

Frye MA, McElroy SL, Fuentes M, Sutor B, Schak KM, Galardy CW, Palmer BA, Prieto ML, Kung S, Sola CL, Ryu E, Veldic M, Geske J, Cuellar-Barboza A, Seymour LR, Mori N, Crowe S, Rummans TA, Biernacka JM.

Int J Bipolar Disord. 2015 Dec;3(1):30. doi: 10.1186/s40345-015-0030-4. Epub 2015 Jun 24.

18.

Clinical risk factors and serotonin transporter gene variants associated with antidepressant-induced mania.

Frye MA, McElroy SL, Prieto ML, Harper KL, Walker DL, Kung S, Chauhan M, Crow S, Sutor B, Galardy CW, Veldic M, Palmer BA, Geske JR, Fuentes M, Cuellar-Barboza AB, Seymour LR, Mori N, Biernacka JM.

J Clin Psychiatry. 2015 Feb;76(2):174-80. doi: 10.4088/JCP.14m09127.

PMID:
25611077
19.

Current landscape, unmet needs, and future directions for treatment of bipolar depression.

Frye MA, Prieto ML, Bobo WV, Kung S, Veldic M, Alarcon RD, Moore KM, Choi DS, Biernacka JM, Tye SJ.

J Affect Disord. 2014 Dec;169 Suppl 1:S17-23. doi: 10.1016/S0165-0327(14)70005-9. Review.

20.

DNA methylation/demethylation network expression in psychotic patients with a history of alcohol abuse.

Guidotti A, Dong E, Gavin DP, Veldic M, Zhao W, Bhaumik DK, Pandey SC, Grayson DR.

Alcohol Clin Exp Res. 2013 Mar;37(3):417-24. doi: 10.1111/j.1530-0277.2012.01947.x. Epub 2012 Sep 7.

PMID:
22958170

Supplemental Content

Loading ...
Support Center